Monolith, 3-1 Nishi-Shinjuku 2-chome
212 articles with Olympus Corporation
Olympus Corporation announced the launch of VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals for endoscopic procedures across multiple medical disciplines.
Olympus announced today the market launch of the Guardenia™ Contained Extraction System.
Olympus announced the availability of the Blue Light Imaging Mode with the ORBEYE™ 4K 3D exoscope system.
World Lung Cancer Day serves as a reminder of the importance of lung cancer screenings among high-risk patients, while also offering an opportunity to highlight the advancement made in early detection and treatment that have helped increase the five-year survival rate for non-small cell lung cancer, the most common kind of lung cancer.
New Olympus OEV321UH Monitor Brings Value, Expansion of 4K Offering and a Range of Compatibility Options for Endoscopy and Surgical Suites
Olympus announced the availability of a new monitor option, the OEV321UH video display monitor, a 32-inch Ultra High Definition 4K monitor that expands upon Olympus 4K monitor offerings.
Olympus Corporation of the Americas, a leading medical technology company, scored 90 out of 100 in its inaugural inclusion on Disability:IN's 2022 Disability Equality Index, a comprehensive tool that helps companies work toward disability inclusion.
Olympus announced it has been awarded a group purchasing agreement in the Single-Use Visualization Devices category for its single-use bronchoscope portfolio with Premier, Inc.
Olympus, a global leader in designing and delivering innovative medical technology solutions, announced its support for the Centers for Medicare & Medicaid Services decision to expand lung cancer screening eligibility for those covered by Medicare.
Olympus announced a strategic co-marketing agreement with Monroe Township, N.J.-based Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business.
Olympus announced the summary results of a follow-up study to measure the durability of the iTind™ procedure for treating the lower urinary tract symptoms caused by BPH.
Olympus announced that its iTind™ procedure for the treatment of enlarged prostate won Gold in the 2022 Medical Design Excellence Awards and Silver in the 2022 Edison Awards.
Olympus announced its support of a new reimbursement from the Centers for Medicare and Medicaid Services that is expected to improve patient access to Endoscopic Submucosal Dissection and for per-oral endoscopic myotomy.
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the release of its latest generation of Guide Sheath™ Kit, designed to facilitate access to lesions in peripheral regions of the lung via bronchoscopy with radial EBUS.
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced it is a 2022 Edison Award Finalist for its iTind™ Procedure, which is nominated within the Science and Medical category for Medical Treatments.
Olympus, a global technology leader in endoscopy, offers a reminder about the importance of screening for colorectal cancer, which may be preventable and treatable when found early.
Olympus announced it has been awarded the new Vizient Single-Use Visualization Devices contract for its single-use bronchoscope portfolio.
Olympus Corporation, has clarified the direction of its medical business with the aim of achieving further growth and profitability by elevating the standard of care in targeted disease states.
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced its support for new lung cancer screening guidelines that could open more at-risk individuals to potentially life-saving scans.
Olympus announced that Anthem Blue Cross Blue Shield, the second largest commercial health plan in the country, has updated their coverage policy to include the Spiration Valve System for patients suffering from severe emphysema, a form of COPD.
Olympus Selected To Exhibit iTind Device For BPH Treatment At Vizient Innovative Technology Exchange
Olympus has been selected to exhibit the iTind™ device, a temporarily implanted device for relief of enlarged prostate symptoms, at the Vizient Innovative Technology Exchange.